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Hsp40 is a co-chaperone of Hsp70 that correctly folds polypeptides that exist in
non-native forms. The C-terminal peptide-binding domain (CTD) of the human
Hsp40 Hdj1 has been puriﬁed and crystallized. In the presence of the C-terminal
octapeptide of human Hsp70, four types of crystals, types I-B, II, III and IV, were
grown and diffracted to 1.85, 2.51, 2.10 and 2.80 A˚ resolution, respectively. In
the absence of the octapeptide, type I-A crystals of the CTD were grown that
diffracted to 2.05 A˚ resolution. The full-length Hdj1 was also puriﬁed and
crystallized (type V crystals); the crystal diffracted to 3.90 A˚ resolution.
1. Introduction
Hsp40 is a co-chaperone of Hsp70 that correctly folds polypeptides
that exist in non-native forms (Frydman et al., 1994). Hsp40 is also
involved in important cellular processes such as protein assembly,
trafﬁcking and the suppression and degradation of non-native poly-
peptides (Hartl & Hayar-Hartl, 2002). Hsp40s have been classiﬁed
into three types: types I, II and III (Cheetham & Caplan, 1998). All of
these types of Hsp40 contain DnaJ-like domains at the N-terminus.
Type I and II Hsp40s contain a C-terminal peptide-binding domain
(CTD) at the C-terminus. Type I Hsp40s also contain zinc-ﬁnger
domains between the DnaJ-like domain and the CTD, whereas type
II Hsp40s do not. Type III Hsp40s consist of the J domain and a
specialized domain such as the clathrin-binding domain found in
auxilin, a mammalian neuronal-speciﬁc protein (Holstein et al., 1996).
During the polypeptide-folding reaction, the CTD of Hsp40 is bound
to the non-native polypeptide and also to the C-terminal EEVD
motif of Hsp70 (Freeman et al., 1995). Hsp40 then delivers the non-
native polypeptide to Hsp70 (Han & Christen, 2003) and the DnaJ-
like domain of Hsp40 stimulates the ATPase activity of Hsp70
(Bukau & Horwich, 1998). Hsp70 refolds the non-native polypeptide
using energy derived from ATP hydrolysis. Recently, the crystal
structure of the CTD of the human type II Hsp40 Hdj1 (Lys158–
Ile340) without ligands has been determined at 2.7 A˚ resolution
(PDB entry 2qld; Hu et al., 2008). However, it remains unclear how
the human Hsp40 recognizes Hsp70 and the non-native polypeptide
owing to a lack of structural information on human Hsp40 complexed
with its ligand. To understand the co-chaperone mechanism of human
Hsp40 from a structural perspective, we have puriﬁed CTDs of the
type II human Hsp40 Hdj1 and crystallized these domains in both the
absence and the presence of the Hsp70 C-terminal octapeptide that
contains the EEVD motif. We have also puriﬁed and crystallized full-
length Hdj1. Here, we report the puriﬁcation and crystallization of
the CTD of Hdj1 and of full-length Hdj1 and preliminary crystallo-
graphic analysis of the crystals.
2. Experimental procedures
2.1. Expression and purification of full-length Hdj1 and the CTDs
2.1.1. Full-length Hdj1. The cDNA for Met1–Ile340 of Hdj1 was
ampliﬁed by the polymerase chain reaction with KOD polymerase
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(Toyobo, Tokyo, Japan) using full-length Hdj1 cDNA as the template.
The PCR product was subcloned between the NdeI and SacI sites
of the pET-23a vector (Novagen, San Diego, California, USA). The
recombinant plasmid was transformed into Escherichia coli BL21
(DE3) pLysS (Novagen) cells. The cells were pre-cultured overnight
at 310 K in 100 ml LB broth containing 100 mg ml1 ampicillin and
34 mg ml1 chloramphenicol. The pre-cultured cells were then
transferred into 7 l LB broth containing 100 mg ml1 ampicillin and
cultured at 310 K. The temperature was lowered to 303 K when the
optical density at 600 nm reached 0.6 and isopropyl -d-1-thio-
galactopyranoside was added to a ﬁnal concentration of 1 mM.
Following 4 h of culturing, the cells were harvested by centrifugation
at 12 000g for 10 min at 277 K, washed once with 150 mM NaCl
solution and resuspended in lysis buffer consisting of 300 mM NaCl,
20 mM HEPES pH 7.5 and 1 mM phenylmethylsulfonyl ﬂuoride
(PMSF). Lysozyme (Sigma–Aldrich, St Louis, Missouri, USA) and
DNase I (Nippon Gene, Tokyo, Japan) were added to the suspended
solution to ﬁnal concentrations of 0.2 mg ml1 and 5 units ml1,
respectively. The suspended cells were lysed by three freeze–thaw
cycles. The lysate was centrifuged at 12 000g for 20 min at 277 K to
remove cell debris. The Hdj1 in the supernatant solution was
precipitated by ammonium sulfate between 1.0 and 1.5M and
collected by centrifugation at 12 000g for 20 min at 277 K. The
collected protein was dissolved in buffer A (100 mM NaCl, 20 mM
HEPES pH 7.5) containing 1 mM PMSF and dialyzed against buffer
A. The dialyzed solution was loaded onto a 100 ml SP-Sepharose
column (GE Healthcare, Piscataway, New Jersey, USA) pre-equili-
brated with buffer B (100 mM NaCl, 50 mM HEPES pH 7.5). The
column was washed with 100 ml buffer B and the protein was eluted
with a linear NaCl gradient from 100 mM to 1M in 360 ml buffer B.
The eluted protein was precipitated with ammonium sulfate between
1.0 and 1.5M and the precipitate was dissolved in buffer C (100 mM
NaCl, 50 mM HEPES pH 7.0) containing 1 mM PMSF. The resultant
solution was dialyzed against buffer C and loaded onto an 8 ml Mono
S cation-exchange column (GE Healthcare) pre-equilibrated with
buffer C. The loaded column was washed with 25 ml buffer C and
Hdj1 was eluted with a linear NaCl gradient from 100 mM to 1M in
50 ml buffer C. The protein sample was concentrated with an Amicon
Ultra-30K concentrator (Millipore, Billerica, Massachusetts, USA)
and applied onto a Superdex 200 10/30 gel-ﬁltration column (GE
Healthcare) pre-equilibrated with buffer A. The gel-ﬁltration chro-
matogram indicated that the puriﬁed Hdj1 forms a dimer.
2.1.2. CTD151–340. CTD151–340 (Ser151–Leu340) was prepared from
full-length Hdj1 by limited proteolysis. Bovine trypsin (Sigma–
Aldrich) was added to the Hdj1 solution that had been partially
puriﬁed using SP Sepharose column chromatography to a 1:24 000
trypsin:Hdj1 ratio by weight and the solution was incubated at 293 K
for 1 h. The proteolysis reaction was stopped by adding 27 mM N--
tosyl-l-lysine chloromethyl ketone hydrochloride (Sigma–Aldrich).
The trypsin-cleaved fragment was precipitated by ammonium sulfate
between 1.5 and 2.0M and puriﬁed using a Mono S cation-exchange
column and a Superdex 75 gel-ﬁltration column as described for the
puriﬁcation of Hdj1. N-terminal amino-acid sequencing and the mass-
spectrometry value of 21 447 Da indicated that the trypsin-cleaved
fragment was Ser151–Leu340 (the calculated molecular weight is
21 440). The gel-ﬁltration chromatogram indicated that the puriﬁed
CTD151–340 forms a dimer.
2.1.3. CTD161–340. The cDNA for Asp161–Ile340 of Hdj1 with an
initial methionine residue at the N-terminus (CTD161–340) was
ampliﬁed by the polymerase chain reaction with KOD polymerase
using full-length Hdj1 cDNA as the template. The PCR product was
subcloned between the NdeI and SalI sites of pET-23a. The resultant
plasmid was transformed into E. coli Rosetta2 (DE3) pLysS cells
(Novagen). Expression, cell lysis, puriﬁcation by ammonium sulfate
fractionation and SP Sepharose column chromatography were
performed as described for the puriﬁcation of full-length Hdj1, except
that CTD161–340 was precipitated by ammonium sulfate between 1.5
and 2.0M. CTD161–340 puriﬁed by SP Sepharose column chromato-
graphy was dialyzed against buffer C and loaded onto an 8 ml
POROS HS cation-exchange column (PerSeptive BioSystems,
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Figure 1
Crystals of type I-A (a), type I-B (b), type II (c),
types III and IV (d) and type V (e).
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Cambridge, Massachusetts, USA) pre-equilibrated with buffer C. The
loaded column was washed with 25 ml buffer C and CTD161–340 was
eluted with 50 ml buffer C containing a linear NaCl gradient from
100 mM to 1M. The protein was concentrated with an Amicon Ultra-
10K concentrator (Millipore, Billerica, Massachusetts, USA) and
applied onto a Superdex 75 10/30 gel-ﬁltration column (GE Health-
care) pre-equilibrated with bufferA. The gel-ﬁltration chromatogram
indicated that the puriﬁed CTD161–340 forms a dimer.
2.1.4. CTD155–340. The cDNA for Pro155–Ile340 of Hdj1 with an
initial methionine residue at the N-terminus (CTD161–340) was
ampliﬁed and subcloned as described for the preparation of the
CTD161–340 plasmid. The resultant plasmid was transformed into
E. coli BL21 (DE3) pLysS cells. Expression and puriﬁcation were
performed as described for the puriﬁcation of CTD161–340.
2.2. Crystallization
All of the CTDs and the full-length Hdj1 were concentrated to the
desired concentrations for crystallization experiments using Amicon
Ultra-10K and Ultra-30K concentrators. Crystallization experiments
were performed by the hanging-drop vapour-diffusion method.
2.2.1. CTD161–340. Crystals of CTD161–340 (type I-A crystals) were
grown from an equivolume mixture of 10 mg ml1 CTD161–340 in
buffer A and a reservoir solution consisting of 13%(w/v) PEG 3350
and 100 mM citrate buffer pH 6.0 at 293 K. Rod-shaped crystals
appeared and grew to typical dimensions of 0.10  0.03  0.50 mm
within 1 d (Fig. 1a). Crystals of CTD161–340 in the presence of the
C-terminal GPTIEEVD octapeptide of human Hsp70 (type I-B
crystals) were grown from an equivolume mixture of 10 mg ml1
CTD161–340 solution containing 4 mM octapeptide at a molar ratio of
1:8.6 and a reservoir solution consisting of 18%(w/v) PEG 3350 and
100 mM citrate buffer pH 6.0 at 277 K. Rod-shaped type I-B crystals
appeared and grew to typical dimensions of 0.07  0.03  0.80 mm
within 1 d (Fig. 1b).
2.2.2. CTD151–340. Crystals of CTD151–340 (type II crystals) were
grown from an equivolume mixture of 20 mg ml1 CTD151–340 in
buffer A containing 4.5 mM octapeptide at a molar ratio of 1:4.8 and
a reservoir solution consisting of 18%(w/v) PEG 3350 and 100 mM
CHES pH 8.8 at 293 K. Rod-shaped type II crystals grew to typical
dimensions of 0.05  0.15  0.60 mm within 1 d (Fig. 1c).
2.2.3. CTD155–340. Type III and IV crystals of CTD155–340 were
grown under the same conditions as the type II crystals. Both crystal
types were rod-shaped and grew to typical dimensions of 0.03  0.07
 0.80 mm within 1 d (Fig. 1d).
2.2.4. Hdj1. Crystals of Hdj1 were grown from an equivolume
mixture of 10 mg ml1 Hdj1 in buffer A and a reservoir solution
consisting of 1.3M ammonium sulfate, 50 mM MES buffer pH 6.4
and 10 mM MgCl2 at 293 K. Under these conditions, only clusters of
needle-shaped crystals with a thickness of less than 0.005 mm could
be obtained. A microseed stock solution was prepared from the
clusters by crushing the crystals in 50 ml buffer D (1.1M ammonium
sulfate, 25 mM MES buffer pH 6.4, 5 mM MgCl2, 10 mM sodium
citrate and 50 mM NaCl) and this solution was diluted to 1 ml using
buffer D. 3 ml of a 5 mg ml1 Hdj1 solution that had been dialyzed
against buffer D was mixed with 0.5 ml of the microseed stock solu-
tion. The mixtures were equilibrated against a reservoir solution
consisting of 1.3M ammonium sulfate, 25 mM MES buffer pH 6.4,
5 mM MgCl2, 10 mM sodium citrate and 50 mM NaCl. Rod-shaped
single crystals of Hdj1 (type V crystals) appeared and grew to typical
dimensions of 0.01 0.01 0.15 mm within 2 d (Fig. 1e). The crystals
were washed several times with the reservoir solution, dissolved in
water and then analyzed by SDS–PAGE (Fig. 2). The PAGE results
showed a single band with the same molecular weight as puriﬁed
Hdj1.
2.3. Diffraction data collection and processing
All diffraction data were processed, integrated and scaled using the
HKL-2000 package (Otwinowski & Minor, 1997). The self-rotation
functions were computed using the programMOLREP implemented
in the CCP4 package (Collaborative Computational Project, Number
4, 1994) based on the diffraction data to a maximum resolution of
4.0 A˚. Diffraction data were also analyzed for pseudo-translational
symmetry using SFCHECK (Vaguine et al., 1999).
2.3.1. CTD161–340. Type I-A and I-B crystals of CTD161–340 soaked
for a few seconds in reservoir solution containing 30% glycerol were
ﬂash-cooled to 95 K. Diffraction data were collected on BL-6A at the
Photon Factory, Tsukuba, Japan. The type I-A and I-B crystals
diffracted to 1.90 and 1.85 A˚ resolution, respectively.
2.3.2. CTD151–340. Type II crystals were soaked for a few seconds
in reservoir solution containing 15%(w/v) PEG 20 000 and 10%(w/v)
PEG 400 and were ﬂash-cooled to 120 K. The diffraction data were
collected using a Cu rotating-anode X-ray generator and an R-AXIS
IV detector (Rigaku, Tokyo, Japan). The type II crystal diffracted to
2.51 A˚ resolution.
2.3.3. CTD155–340. Type III and IV crystals of CTD155–340 were
soaked for a few seconds in reservoir solution containing 15%(w/v)
PEG 20 000 and 10%(w/v) PEG 400 and were ﬂash-cooled to 100 K.
The diffraction data were collected on BL38B1 at SPring-8, Harima,
Japan. The type III and IV crystals diffracted to 1.90 and 2.80 A˚
resolution, respectively.
2.3.4. Hdj1. Type V crystals of Hdj1 were soaked for a few seconds
in reservoir solution containing 30% glycerol and were ﬂash-cooled
to 95 K. Diffraction data were collected on BL-17A at the Photon
Factory. The crystal diffracted to 3.8 A˚ resolution.
3. Results and discussion
The data-collection statistics of the diffraction data, together with the
unit-cell parameters, are presented in Table 1. Complete diffraction
data were collected for all of the CTD crystals, but not for Hdj1.
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Figure 2
SDS–PAGE analysis of a full-length Hdj1 crystal. Lane 1, molecular-weight
markers; molecular weights are labelled in kDa on the left. Lane 2, dissolved
crystals of full-length Hdj1. Silver staining was used for protein detection.
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The type I-A and type I-B crystals of CTD161–340 both belonged to
space group P21 and their unit-cell parameters are similar to each
other, although the unit-cell volume of the type I-B crystal, which was
grown in the presence of the octapeptide, is 2% larger than that of the
type I-A crystal grown in the absence of the octapeptide. Type I-B
crystals were obtained at a higher concentration of PEG 3350 than
that used for type I-A crystals. This observation indicates that the
octapeptide enhanced the solubility of CTD161–340 and the type I-B
crystals diffracted to a higher resolution than the type I-A crystals.
These differences may have been caused by the formation of the
CTD161–340–octapeptide complex in the type I-B crystals; however,
conﬁrmation of the formation of a complex requires crystal structure
determination. Assuming the presence of one dimer of CTD161–340
per asymmetric unit, the VM values are 3.21 and 3.28 A˚
3 Da1 and the
calculated solvent contents are 61.8 and 62.6%, respectively
(Matthews, 1968). This is consistent with the presence of a noncrys-
tallographic twofold axis, as indicated by the self-rotation functions,
in which clear peaks 13 and 17 above the average were observed at
( = 18, ’ = 0) in the  = 180 section for the type I-A and I-B
crystals, respectively.
The type II crystals of CTD151–340 and the type III crystals of
CTD155–340 belonged to space group C2 and their unit-cell parameters
are nearly identical. Assuming the presence of one dimeric CTD per
asymmetric unit, their VM values are 2.70 and 2.76 A˚
3 Da1 and their
calculated solvent contents are 54.4 and 55.4%, respectively. Never-
theless, no clear peak could be observed in the  = 180 section of the
self-rotation function for either type of crystal. The CTD of Hsp40
consists of three subdomains (Sha et al., 2000; Hu et al., 2008). The
absence of noncrystallographic twofold symmetry may be a conse-
quence of the subdomain arrangements of the two protomers of
CTD151–340 differing from each other in these types of crystals.
Alternatively, the noncrystallographic twofold axis may be parallel to
the crystallographic twofold or 21 screw axes.
The type IV crystal belonged to space group C2 and the volume of
the asymmetric unit was the largest of the CTD crystals examined.
Assuming the presence of two dimers of CTD155–340 per asymmetric
unit, the VM value is 2.68 A˚
3 Da1 and the calculated solvent content
is 54.2%. No clear peak could be observed in the  = 180 section
of the self-rotation function. In a native Patterson map, a non-origin
peak was observed at (0.500, 0.410, 0.500), indicating the presence
of pseudo-translational symmetry. The two dimers of CTD155–340 in
the asymmetric unit, as suggested by the VM value, may be related by
this pseudo-translational symmetry.
Of the three kinds of CTDs, those with the longer N-termini,
CTD151–340 and CTD155–340, only crystallized in the presence of the
octapeptide and under alkaline conditions around pH 9. In contrast,
the CTD with the shortest N-terminus, CTD161–340, crystallized under
slightly acidic conditions at pH 6 and crystallized in both the presence
and the absence of the octapeptide. The length of the N-terminus also
affected the reproducibility of the crystals: type I-A and I-B crystals
of CTD161–340 diffracted to the maximum resolution shown in Table 1
with nearly 100% reproducibility, whereas the reproducibilities of the
type II crystal of CTD151–340 and the type III and IV crystals of
CTD155–340 that diffracted to maximum resolution were less than 5%.
Determination of the structure of the type I-A crystal by the single
isomorphous replacement method with anomalous scattering and its
crystallographic reﬁnement are in progress. Determination of the
structures of the type I-B, II, III and IV crystals were performed by
the molecular-replacement method using the type I-A crystal struc-
ture as a search model. Inspection of the preliminary electron-density
maps revealed that the octapeptides were bound to two discrete sites,
1 and 2, as shown in Supplementary Fig. S11. Crystallographic
reﬁnements of these structures are under way.
Despite the weak diffraction of the type V crystals, the diffraction
data revealed that the crystals belonged to space group P21; assuming
the presence of one dimer of Hdj1 per asymmetric unit, the VM value
is 2.40 A˚3 Da1 and the calculated solvent content is 48.7%. This is
the only reported case in which full-length Hsp40 has been crystal-
lized. Although the resolution and completeness of the diffraction
data of the type V crystal are low, structure determination of the type
V crystal may be possible using the molecular-replacement method.
The crystal structure should provide insight into the domain
arrangement of full-length Hsp40.
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Table 1
X-ray data-collection statistics.
Values in parentheses are for the highest resolution shell.
Crystal Type I-A Type I-B Type II Type III Type IV Type V
Construct Asp161–Ile340 Asp161–Ile340 Ser151–Ile340 Pro155–Ile340 Pro155–Ile340 Met1–Ile340
Crystal data
Space group P21 P21 C2 C2 C2 P21
Unit-cell parameters
a (A˚) 103.3 104.7 111.1 111.1 193.1 106.3
b (A˚) 40.9 41.1 50.9 51.3 40.6 41.0
c (A˚) 62.7 62.9 90.2 90.2 128.6 95.3
 () 96.6 97.4 114.8 114.8 115.8 116.9
VM (A˚
3 Da1) 3.21 3.28 2.70 2.76 2.68 2.40
Solvent content (%) 61.8 62.6 54.4 55.4 54.2 48.7
No. of protomers per ASU 2 2 2 2 4 2
Diffraction data statistics
Wavelength (A˚) 0.9780 0.9780 1.5418 0.9000 0.9000 0.9500
Resolution (A˚) 102.6–2.05 (2.12–2.05) 103.7–1.85 (1.90–1.85) 81.9–2.51 (2.57–2.51) 81.9–2.10 (2.18–2.10) 115.5–2.80 (2.90–2.80) 50.0–3.90 (3.97–3.90)
No. of observed reﬂections 169938 389035 90145 230072 186082 22078
No. of unique reﬂections 33295 43147 14847 26399 22693 5038
Redundancy 5.1 (3.5) 9.0 (3.4) 6.1 (4.6) 8.7 (5.5) 8.2 (7.3) 4.4 (4.1)
Completeness (%) 99.1 (96.6) 99.1 (96.9) 98.2 (87.1) 99.7 (98.2) 99.9 (99.7) 72.2 (58.5)
hI/(I)i 23.6 (3.3) 23.1 (1.5) 21.4 (3.3) 25.8 (3.0) 30.6 (4.1) 13.6 (6.3)
Rmerge† 0.100 (0.420) 0.056 (0.482) 0.058 (0.386) 0.104 (0.408) 0.106 (0.391) 0.269 (0.499)
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ.
1 Supplementary material has been deposited in the IUCr electronic archive
(Reference: UO5011).
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(HS). The synchrotron-radiation experiments were performed under
the approval of the Photon Factory Program Advisory Committee
(Proposal No. 2008G141) and of the Japan Synchrotron Radiation
Research Institute (JASRI; Proposal No. 2008B1179).
References
Bukau, B. & Horwich, A. L. (1998). Cell, 92, 351–366.
Cheetham, M. E. & Caplan, A. J. (1998). Cell Stress Chaperone, 3, 28–36.
Collaborative Computational Project, Number 4 (1994). Acta Cryst. D50,
760–763.
Freeman, B. C., Myers, M. P., Schumacher, R. & Morimoto, R. I. (1995).
EMBO J. 14, 2281–2292.
Frydman, J., Nimmesgern, E., Ohtsuka, K. & Hartl, F. U. (1994). Nature
(London), 370, 111–117.
Han, W. & Christen, P. (2003). J. Biol. Chem. 278, 19038–19043.
Hartl, F. U. & Hayar-Hartl, M. (2002). Science, 295, 1852–1858.
Holstein, S. E., Ungewickell, H. & Ungewickell, E. (1996). J. Cell Biol. 135,
925–937.
Hu, J., Wu, Y., Li, J., Qian, X., Fu, Z. & Sha, B. (2008). BMC Struct. Biol. 8, 3.
Matthews, B. W. (1968). J. Mol. Biol. 33, 491–497.
Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 276, 344–358.
Sha, B., Lee, S. & Cyr, D. M. (2000). Structure, 8, 799–807.
Vaguine, A. A., Richelle, J. & Wodak, S. J. (1999). Acta Cryst. D55, 191–205.
crystallization communications
Acta Cryst. (2010). F66, 1591–1595 Suzuki et al.  Hdj1 1595
electronic reprint
Supplementary Figure S1 
Fo - Fc difference Fourier maps of the octapeptides. The maps are calculated at maximum 
resolution shown in Table 1 using the model obtained from the molecular-replacement method by 
MOLREP. The maps at sites 1 and 2 are coloured in blue and green, respectively. Preliminary 
CTD and octapeptide models are shown as Cα traces in orange and magenta, respectively. (a) Site 
1 of type I-B crystal, contoured at 1.5σ. (b) Site 2 of type I-B crystal, contoured at 1.5σ. (c) Site 1 
of type II crystal, contoured at 1.6σ. (d) Site 2 of type I-B crystal, contoured at 1.6σ. (e) Site 1 of 
type III crystal, contoured at 1.5σ. (f) Site 2 of type III crystal, contoured at 1.3σ. (g) Site 1 of 
type IV crystal, contoured at 1.5σ. (h) Site 2 of type IV crystal, contoured at 1.5σ. 
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